Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0041 | 0.1177 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.0785 | 0.0661 |
Schistosoma mansoni | tripeptidyl-peptidase II (S08 family) | 0.0263 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0016 | 0.0216 | 0.0792 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0016 | 0.0216 | 0.0792 |
Wolbachia endosymbiont of Brugia malayi | 4'-phosphopantetheinyl transferase | 0.0023 | 0.0483 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0041 | 0.1177 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0041 | 0.1177 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.1177 | 1 |
Chlamydia trachomatis | holo [acyl-carrier protein] synthase | 0.0023 | 0.0483 | 0.5 |
Brugia malayi | polk-prov protein | 0.0031 | 0.0785 | 0.0661 |
Echinococcus multilocularis | Peptidase S8 S53, subtilisin kexin sedolisin | 0.0098 | 0.3472 | 1 |
Trypanosoma brucei | unspecified product | 0.0034 | 0.0918 | 0.7519 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.1177 | 1 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0021 | 0.0392 | 0.7405 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0031 | 0.0785 | 0.6246 |
Entamoeba histolytica | hypothetical protein | 0.0023 | 0.0483 | 1 |
Brugia malayi | POT family protein | 0.0085 | 0.2955 | 0.286 |
Treponema pallidum | 4'-phosphopantetheinyl transferase | 0.0023 | 0.0483 | 0.5 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0041 | 0.1177 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0031 | 0.0785 | 0.6246 |
Mycobacterium leprae | conserved hypothetical protein | 0.0023 | 0.0483 | 0.5 |
Brugia malayi | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | 0.0082 | 0.283 | 0.2733 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.1177 | 1 |
Toxoplasma gondii | 4'-phosphopantetheinyl transferase domain-containing protein | 0.0023 | 0.0483 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.1177 | 1 |
Echinococcus granulosus | dna polymerase kappa | 0.0041 | 0.1177 | 0.3128 |
Onchocerca volvulus | 0.0082 | 0.283 | 0.5 | |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0016 | 0.0216 | 0.0792 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0041 | 0.1177 | 1 |
Plasmodium vivax | holo-[acyl-carrier-protein] synthase, putative | 0.0023 | 0.0483 | 0.5 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0041 | 0.1177 | 0.5 |
Echinococcus granulosus | peptidase s8 s53 subtilisin kexin sedolisin | 0.0098 | 0.3472 | 1 |
Loa Loa (eye worm) | POT family protein | 0.0085 | 0.2955 | 0.286 |
Giardia lamblia | DINP protein human, muc B family | 0.0021 | 0.0392 | 0.5 |
Schistosoma mansoni | aminoadipate-semialdehyde dehydrogenase | 0.0082 | 0.283 | 0.2733 |
Loa Loa (eye worm) | subtilase | 0.0263 | 1 | 1 |
Echinococcus multilocularis | L aminoadipate semialdehyde | 0.0082 | 0.283 | 0.8078 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.1177 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0021 | 0.0392 | 0.2481 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0034 | 0.0918 | 0.7519 |
Plasmodium falciparum | holo-[acyl-carrier-protein] synthase, putative | 0.0023 | 0.0483 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.1177 | 1 |
Echinococcus granulosus | L aminoadipate semialdehyde | 0.0082 | 0.283 | 0.8078 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0041 | 0.1177 | 0.5 |
Toxoplasma gondii | 4'-phosphopantetheinyl transferase superfamily protein | 0.0023 | 0.0483 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0041 | 0.1177 | 1 |
Leishmania major | DNA polymerase kappa, putative | 0.0021 | 0.0392 | 0.7405 |
Echinococcus multilocularis | dna polymerase kappa | 0.0041 | 0.1177 | 0.3128 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.1177 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0082 | 0.283 | 0.2733 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.1177 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0023 | 0.0483 | 0.3351 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0021 | 0.0392 | 0.7405 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.1177 | 1 |
Mycobacterium tuberculosis | holo-[acyl-carrier protein] synthase AcpS (holo-ACP synthase) (CoA:APO-[ACP]pantetheinephosphotransferase) (CoA:APO-[acyl-carrie | 0.0023 | 0.0483 | 1 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0041 | 0.1177 | 1 |
Leishmania major | phosphopantetheinyl transferase-like protein | 0.0023 | 0.0483 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0041 | 0.1177 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 44.2 uM | Inhibition of human recombinant SIRT1 | ChEMBL. | 19419202 |
Inhibition (binding) | = 12.7 % | Inhibition of human recombinant SIRT2 at 60 uM | ChEMBL. | 19419202 |
Inhibition (binding) | = 36.1 % | Inhibition of human recombinant SIRT2 expressed in Escherichia coli at 50 uM incubated at 37 degC for 2 hrs by Fluor de Lys fluorescence assay | ChEMBL. | 21306905 |
Inhibition (binding) | = 83.2 % | Inhibition of human recombinant SIRT1 at 60 uM | ChEMBL. | 19419202 |
Inhibition (binding) | = 83.2 % | Inhibition of human recombinant SIRT1 expressed in Escherichia coli at 50 uM incubated at 37 degC for 2 hrs by Fluor de Lys fluorescence assay | ChEMBL. | 21306905 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.